FDA Inspection 1187470 — MedAire, Inc.
The FDA completed an inspection of MedAire, Inc. on October 13, 2022 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 13, 2022
- Fiscal Year
- 2023
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Phoenix, AZ (United States)